Medicines (Marketing Authorisation) (Amendment)Regulations, 2013

This regulation amends existing rules concerning the authorisation of medicines for sale within the EU. It aims to update procedures and potentially streamline the process for drug approval. The changes affect pharmaceutical companies seeking to market their products and may impact the availability and regulation of medicines for consumers across member states.